Peter Pisters: 2024 was an extraordinary year thanks to the dedication of MD Anderson Cancer Center
Peter Pisters, President of The University of Texas MD Anderson Cancer Center, shared MD Anderson Cancer Center’s post on X, adding:
“Thanks to the dedication and teamwork of our 27,000 MD Anderson Cancer Center teammates, 2024 was an extraordinary year. As we step into 2025, I am filled with gratitude for the continued opportunity to work together in service of our patients and the mission we share to End Cancer.”
Quoting MD Anderson Cancer Center’s post:
“As we get ready to welcome 2025, we look back at the advances made in 2024.
We are grateful to our patients and their families who trust us with their care, as well as our donors, employees, volunteers, students and trainees who make these advances possible.”
Proceed to the video attached to the post.
More posts featuring Peter Pisters and MD Anderson Cancer Center.
Peter Pisters leads The University of Texas MD Anderson Cancer Center, driving research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine, and rehabilitation medicine.
He contributes to academic journals like the Journal of Clinical Oncology and Surgery, and reviews for various publications. His research, concentrated on sarcomas, GI cancers, and other malignancies.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023